about
Doloplus-2, a valid tool for behavioural pain assessment?APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central NorwayValidation of Doloplus-2 among nonverbal nursing home patients--an evaluation of Doloplus-2 in a clinical setting.The effect of a pre- and postoperative orthogeriatric service on cognitive function in patients with hip fracture: randomized controlled trial (Oslo Orthogeriatric Trial).Unwanted incidents during transition of geriatric patients from hospital to home: a prospective observational studyMental health and wellbeing in spouses of persons with dementia: the Nord-Trøndelag Health Study.Association between blood pressure and Alzheimer disease measured up to 27 years prior to diagnosis: the HUNT Study.Effect of in-hospital comprehensive geriatric assessment (CGA) in older people with hip fracture. The protocol of the Trondheim Hip Fracture trialDevelopment and delivery of patient treatment in the Trondheim Hip Fracture Trial. A new geriatric in-hospital pathway for elderly patients with hip fracture.The effect of a pre- and post-operative orthogeriatric service on cognitive function in patients with hip fracture. The protocol of the Oslo Orthogeriatrics Trial.The brain structural and cognitive basis of odor identification deficits in mild cognitive impairment and Alzheimer's disease.The long-term effect of being treated in a geriatric ward compared to an orthopaedic ward on six measures of free-living physical behavior 4 and 12 months after a hip fracture - a randomised controlled trial.Who benefits from orthogeriatric treatment? Results from the Trondheim hip-fracture trial.Alcohol consumption and risk of dementia up to 27 years later in a large, population-based sample: the HUNT study, NorwayVisual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.Effectiveness of task specific gait and balance exercise 4 months after hip fracture: protocol of a randomized controlled trial--the Eva-hip study.Which cancer patients die in nursing homes? Quality of life, medical and sociodemographic characteristics.Patterns of drug prescriptions in an orthogeriatric ward as compared to orthopaedic ward: results from the Trondheim Hip Fracture Trial-a randomised clinical trial.Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients.MRI-assessed atrophy subtypes in Alzheimer's disease and the cognitive reserve hypothesis.Long-chain n-3 fatty acids and mortality in elderly patients.Physical behavior and function early after hip fracture surgery in patients receiving comprehensive geriatric care or orthopedic care--a randomized controlled trial.Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomised study.The association of high sensitivity C-reactive protein and incident Alzheimer disease in patients 60 years and older: The HUNT study, Norway.Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics.Trajectories of depressive symptoms and their relationship to the progression of dementia.One-year health and care costs after hip fracture for home-dwelling elderly patients in Norway: Results from the Trondheim Hip Fracture Trial.Reduced mortality in treating acutely sick, frail older patients in a geriatric evaluation and management unit. A prospective randomized trial.Dementia and neuropsychiatric symptoms in nursing-home patients in Nord-Trøndelag County.Comprehensive geriatric care for patients with hip fractures: a prospective, randomised, controlled trial.Cohort profile: the Health and Memory Study (HMS): a dementia cohort linked to the HUNT study in Norway.Association between vascular comorbidity and progression of Alzheimer's disease: a two-year observational study in Norwegian memory clinics.Environmental factors and risk of delirium in geriatric patients: an observational studyThe Norwegian Cognitive impairment after stroke study (Nor-COAST): study protocol of a multicentre, prospective cohort studyGenetic meta-analysis identifies 9 novel loci and functional pathways for Alzheimers disease riskMeta-analysis of Alzheimer’s disease on 9,751 samples from Norway and IGAP study identifies four risk lociRandomised Trial of In-Hospital Geriatric Intervention: Impact on Function and MoraleThe Norwegian Doloplus-2, a tool for behavioural pain assessment: translation and pilot-validation in nursing home patients with cognitive impairmentAcute geriatric intervention increases the number of patients able to live at home. A prospective randomized studyGenome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
P50
Q33311381-A4C5DEFF-1A0B-4C43-9316-798A512345E0Q33328700-712E68CC-5322-43FA-8D9E-7C15E9A3D959Q33532801-BAEAA7DB-B782-4F39-9D03-D29EF7BE6385Q33616783-5942AEB8-A179-479C-A288-19EE2860C0F0Q33683463-A1EC2745-6B2D-4321-98DE-0200530BE554Q33697081-1539399A-5337-47FF-8907-8527FCAE996CQ33749775-0F7277E8-10C7-431D-A817-47643FCB56ACQ33879056-315C7CAB-0D86-490C-8C53-B5C74EA35C55Q34338712-09BB0996-9908-4DA3-B81B-0FB2C92B661DQ34346187-5D8BC0F2-5A4E-4DB7-91C5-60030D9CB3A1Q34538738-E5A1CD17-439D-4E37-889F-6F83D1F19FD7Q35861283-A83860E5-B736-4E5F-B6E6-AC15439B1B87Q35928893-DDC48AA1-F970-4280-B1A2-FE1C211826C0Q36095770-FF7A56FF-4975-4CDD-9BFC-A830722DCB2EQ38725605-841577FE-9341-491E-B6BD-928D313D21F2Q39164560-64B6368E-0030-4A16-B4CC-C4A8D0114BE3Q40572367-48B4593E-2752-47C4-8984-596E875C89D9Q40999858-D6D15832-A81A-4252-8385-DD909D693D2CQ41282581-2395E9C1-7B90-430E-8960-D54F0ED3E68BQ42696088-04BB4FDE-F099-40F3-BC5A-C4F9FA712BCBQ44929425-A8786D85-F24F-4AF3-AF18-C0B1C95ACD26Q46213950-FC5C15BD-632B-421D-B023-F05D9831D155Q46819497-27A44838-F4A7-48B5-BD5A-246FA8CED94BQ47550084-93CA16C4-595A-42E7-BB38-20A2D0A722E4Q47563025-7A2ECE0D-7574-4511-972B-C77FA660E369Q47828045-2D7B6DD1-8684-4689-8E39-101DD81A038EQ47955617-7D6FA28D-58DF-4247-AC62-C0F5AED123E3Q50487759-7F95EE45-0B05-4A0A-A684-BF2EAB5D9009Q50556292-5D959DAA-0DB4-4864-89BF-26DD2C163921Q50587019-3CFD2659-8D91-4DC6-86ED-D3F3D384F8D6Q50659882-B339C72D-953D-4783-A1F5-C9710703FB98Q55257582-B2A58876-042F-4E36-85ED-341700B061D7Q59337365-4EC67D14-1AFD-4E1A-B6A3-98198776F7ECQ59808473-6F7444C7-E228-4D78-A53A-53394A46A945Q59843529-A9C960B1-3CAA-4B0F-B240-1119411C078FQ60303872-5843B3FF-7013-422E-8BDA-10D3CD350A43Q60716142-1CA5E8CB-E06F-4C7B-A09E-2431F9F9EBCAQ60716156-F5C5AE79-654E-4ECA-96BC-2E9763736BE6Q60716161-DE27DC1A-23DD-40F0-91F8-E832360EC8C6Q62840254-DFD987C6-B8A9-4C77-8D91-9371F681148C
P50
description
Noors onderzoekster
@nl
hulumtuese
@sq
norsk forsker
@nb
researcher
@en
ricercatrice
@it
taighdeoir
@ga
հետազոտող
@hy
name
Ingvild Saltvedt
@ast
Ingvild Saltvedt
@da
Ingvild Saltvedt
@de
Ingvild Saltvedt
@en
Ingvild Saltvedt
@es
Ingvild Saltvedt
@fr
Ingvild Saltvedt
@ga
Ingvild Saltvedt
@nb
Ingvild Saltvedt
@nl
Ingvild Saltvedt
@nn
type
label
Ingvild Saltvedt
@ast
Ingvild Saltvedt
@da
Ingvild Saltvedt
@de
Ingvild Saltvedt
@en
Ingvild Saltvedt
@es
Ingvild Saltvedt
@fr
Ingvild Saltvedt
@ga
Ingvild Saltvedt
@nb
Ingvild Saltvedt
@nl
Ingvild Saltvedt
@nn
altLabel
Ingvild T. Saltvedt
@nb
Ingvild Tina Saltvedt
@nb
prefLabel
Ingvild Saltvedt
@ast
Ingvild Saltvedt
@da
Ingvild Saltvedt
@de
Ingvild Saltvedt
@en
Ingvild Saltvedt
@es
Ingvild Saltvedt
@fr
Ingvild Saltvedt
@ga
Ingvild Saltvedt
@nb
Ingvild Saltvedt
@nl
Ingvild Saltvedt
@nn
P106
P21
P214
9228149296217880670006
P27
P31
P496
0000-0002-7897-9808
P569
1960-01-01T00:00:00Z
P7859
viaf-9228149296217880670006